default author photo

Andrea Forschner

University of Tübingen

Tübingen, 72074

Germany

SCHOLARLY PAPERS

4

DOWNLOADS

243

TOTAL CITATIONS

0

Scholarly Papers (4)

1.

Nomogram for Predicting Survival after First-Line Anti-Pd-1 Immunotherapy in Unresectable Stage IV Melanoma: A Multicenter International Study

Number of pages: 29 Posted: 21 Dec 2023
University of Tübingen, University of Tübingen, Charité - Universitätsmedizin Berlin, Military Medical Academy of Belgrade, Military Medical Academy of Belgrade, Dresden University of Technology, Kantonsspital St Gallen, Hospital Universitario Gregorio Marañón, Centro Hospitalar e Universitário do Algarve, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen - Centre for Dermatooncology, University Clinical Centre of Serbia, University Clinical Centre of Serbia, Dresden University of Technology, Charité - Universitätsmedizin Berlin, University of Tübingen, University of Tübingen, University of Tübingen and University of Tübingen - Centre for Dermatooncology
Downloads 86 (765,566)

Abstract:

Loading...

nomogram, melanoma, survival, checkpoint inhibitors, anti-PD-1, first line, stage IV

2.

CLAUDIUS Study: Risk of Materno-Fetal Transmission of Melanoma Cells in Pregnant Women with High Grade Melanoma – A Retrospective Multicenter Study and Literature Review

Number of pages: 30 Posted: 04 May 2023
Heidelberg University - Department of Dermatology, Heidelberg University - Department of Dermatology, Medical University of Innsbruck, Friedrich Alexander University Erlangen Nuremberg, University of Cologne - University Hospital of Cologne, Fachklinik Hornheide, Heinrich Heine University Dusseldorf, Dresden University of Technology, Johann Wolfgang Goethe-Universität Frankfurt, University Hospital Regensburg, Saarland University - Medical School, University Hospital Münster, Helios Klinikum Erfurt, Paracelsus Medical University Nuremberg - General Hospital Nuremberg, Ruhr-University Bochum, University of Rostock - Rostock University Medical Center, University Hospital Augsburg, University of Greifswald - University Medicine Greifswald, Ludwigshafen Medical Center, University of Tübingen, Friedrich-Schiller-Universität Jena, Ludwig Maximilian University of Munich (LMU) - University Hospital of Munich, Hôpital Saint-Louis, University of Oldenburg, Otto von Guericke University Magdeburg, Vivantes Klinikum im Friedrichshain, Vivantes Klinikum im Friedrichshain, Charité - Universitätsmedizin Berlin, Hospital BremerhavenReinkenheide, Ulm University, Klinikum Darmstadt, University Leipzig - Department of Dermatology, Venereology and Allergology, Klinikum Bremen-Ost, Ruhr-University Bochum, Brandenburg Medical School Theodor Fontane, Helios-Klinikum Hildesheim, University of Wuppertal, Heidelberg University - Department of Dermatology and Heidelberg University - Department of Dermatology
Downloads 77 (823,616)

Abstract:

Loading...

Melanoma, Multicentre, paediatric oncology, pregnancy, Retrospective, Transplacental Metastases

3.

Identification of Stage I and II Melanoma Patients at High Risk for Recurrence Using a Model Combining Clinicopathologic Factors with Gene Expression Profiling (CP-GEP)

Number of pages: 19 Posted: 30 Nov 2022
University of Tübingen - Centre for Dermatooncology, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, University of Tübingen, SkylineDx BV, SkylineDx BV, SkylineDx BV, University of Tübingen, Princess Máxima Center for Pediatric Oncology and University of Tübingen
Downloads 55 (1,010,164)

Abstract:

Loading...

early stage melanoma, CP-GEP, biomarkers, adjuvant therapy, risk stratification

4.

Sex-Specific Survival in Advanced Metastatic Melanoma – a Decog Study on 2032 Patients of the Multicenter Prospective Skin Cancer Registry Adoreg

Number of pages: 24 Posted: 06 Jun 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Schleswig-Holstein University, Elbe Kliniken Buxtehude, Dresden University of Technology, affiliation not provided to SSRN, University Hospital Mühlenkreiskliniken Minden, Heidelberg University - Department of Dermatology, University of Lubeck, Helios Klinikum Erfurt, University Hospital Regensburg, Saarland University - Medical School, University of Tübingen, University of Tübingen, University of Witten/Herdecke - Witten/Herdecke University Hospital, University Medical Center Hamburg- Eppendorf, affiliation not provided to SSRN, Universitätsklinikum Münster, affiliation not provided to SSRN, Paracelsus Medical University Nuremberg - General Hospital Nuremberg, Heidelberg University - University Hospital Heidelberg, University Hospital Augsburg, Ludwig Maximilian University of Munich (LMU), University Hospital Erlangen, affiliation not provided to SSRN, affiliation not provided to SSRN, Leipzig University, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, University of Duisburg-Essen - University Hospital Essen, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 25 (1,385,945)

Abstract:

Loading...

Melanoma, sex, Targeted therapy, immune checkpoint inhibition therapy, Survival